CoMind Early Feasibility Study

NCT ID: NCT06368648

Last Updated: 2026-02-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

581 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-11-27

Study Completion Date

2026-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this research, which has been determined as non-significant risk by the central IRB overseeing the study, is to obtain information to help further develop a machine (a medical device) to measure the pressure around the brain from the outside (this pressure is called intracranial pressure or ICP). Monitoring and managing ICP is an important part of care for patients with conditions such as Traumatic Brain Injury (TBI). However, the current way of measuring ICP requires surgery to drill a hole into the skull, and therefore can introduce additional risks such as infections and pain.

Recent research has shown it may be possible to measure ICP without needing surgery. This technology is in development, but large amounts of data is required to build these new devices.

Through collecting a large database of information from patients who have both the routine surgical device and the research device applied to their head, the research team will work to develop and test an effective and potentially safer way of monitoring patient ICP.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A prospective, observational study, determined as non-significant risk by the Central IRB, to assess and improve performance of a non-invasive ICP estimation system. The development of non-invasive systems is intended to replace the need for invasive ICP monitors. Participants serve as their own controls with concurrent, synchronous measurements of ICP (measured invasively as per standard clinical practice), Arterial Blood Pressure (ABP- measured invasively as per standard clinical practice), and measurements of a novel non- invasive cerebral blood-flow index (CBFi) from the CoMind One EFS device. These signals will be recorded simultaneously. The ABP and CBFi will serve as inputs to a model which outputs a non-invasive estimate of ICP, and the invasive ICP signal will be used to supervise and evaluate the performance of the non-invasive ICP estimation model. A large volume of data shall be collected for the purposes of training and testing the non-invasive ICP model. The Sponsor will report limits of agreement (LOA) between data-driven estimates of ICP and the invasively measured signal. In addition, this study will compare metrics built on non-invasive estimation of ICP or CBFi that indicate the state of CAR, and the limits of Autoregulation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intracranial Pressure Intracranial Pressure Changes Traumatic Brain Injury Intracerebral Hemorrhage Encephalitis Encephalopathy Hydrocephalus Stroke Autoregulation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients receiving invasive ICP and ABP monitoring as their standard of care

Patients who are receiving invasive Intracranial Pressure (ICP) monitoring and invasive Arterial Blood Pressure (ABP) monitoring as per standard practice will serve as their own controls.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Male or female sex at birth, and aged 18 years or older on the date of enrollment.
2. Receiving continuous invasive ICP monitoring (Bolt or EVD) as part of standard care.
3. Invasive ICP monitor catheter penetrating the parenchyma or ventricles.
4. Receiving continuous invasive ABP monitoring as part of standard care.

Exclusion Criteria

1. Presence of any implant (cosmetic or otherwise) in the frontal bone in such proximity to the CoMind One EFS Sensor that they might physically touch.
2. Open wounds on the forehead such that CoMind One EFS Sensor cannot be safely placed over an area of intact skin
3. Presenting with radiographic evidence of a non-intact skull at the recording site on admission.
4. If patient is enrolled in an intervention/study that may interfere with SoC ICP measurements or the CoMind One EFS device measurement then the patient is ineligible.
5. Patients with decompressive craniectomy will be excluded unless a CoMind One EFS recording can be made from intact skull.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Lindus Health

INDUSTRY

Sponsor Role collaborator

CoMind Technologies Limited

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ramani Balu, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Inova Fairfax Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

UC Davis Medical Center

Sacramento, California, United States

Site Status RECRUITING

Christiana Care

Wilmington, Delaware, United States

Site Status ACTIVE_NOT_RECRUITING

Medstar Health

Washington D.C., District of Columbia, United States

Site Status NOT_YET_RECRUITING

Jackson Memorial Hospital

Miami, Florida, United States

Site Status RECRUITING

The University of Kansas Medical Center

Kansas City, Kansas, United States

Site Status ACTIVE_NOT_RECRUITING

Washington University Medical Center

St Louis, Missouri, United States

Site Status RECRUITING

Albany Medical College

Albany, New York, United States

Site Status ACTIVE_NOT_RECRUITING

Stony Brook University Hospital

Stony Brook, New York, United States

Site Status NOT_YET_RECRUITING

WakeMed

Raleigh, North Carolina, United States

Site Status RECRUITING

Ohio State University

Columbus, Ohio, United States

Site Status RECRUITING

University of Pennsylvania Hospital

Philadelphia, Pennsylvania, United States

Site Status NOT_YET_RECRUITING

Vanderbilt University Medical Center

Nashville, Tennessee, United States

Site Status RECRUITING

Inova Fairfax Medical Campus

Falls Church, Virginia, United States

Site Status ACTIVE_NOT_RECRUITING

University of Washington, Harborview

Seattle, Washington, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

David Diedo

Role: CONTACT

305-290-1680

Blake Butler

Role: CONTACT

8554493806

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Trial Coordinator

Role: primary

916-551-3234

Trial Coordinator

Role: primary

2028773519

Trial Coordinator

Role: primary

305-243-3056

Trial Coordinator

Role: primary

3142732240

Trial Coordinator

Role: primary

631-444-2970

Research Coordinator

Role: primary

919-350-7026

Research Coordinator

Role: primary

(614) 293-3559

Trial Coordinator

Role: primary

267-254-4745

Research Nurse Specialist

Role: primary

615-875-1969

Research Coordinator

Role: primary

206-744-4634

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CP-1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Human Intracranial Electrophysiology
NCT05529264 RECRUITING NA
Localizing Epileptic Networks Using MRI and iEEG
NCT04649008 RECRUITING EARLY_PHASE1
Diagnosing Epilepsy To EffeCT Change
NCT07110337 ENROLLING_BY_INVITATION PHASE4
Microelectrodes in Epilepsy
NCT05200455 COMPLETED NA